Bodal Chemicals Ltd (BODALCHEM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Bodal Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
Bodal Chemicals Limited herewith submit conn call audio link
Audio / Video · 04 Nov 2026, 12:22 am
Bodal Chemicals Releases 2QFY27 and 1HFY27 Earnings Conference Call Audio Recording Bodal Chemicals has made available the audio recording of its analyst conference call held on 3rd Nov'26, pursuant to Regulation 46 of SEBI LODR Regulations. The call addressed the company's financial performance for the quarter and half-year ended 30th Sep'26 (2QFY27/1HFY27). Market participants can access the full audio web link directly via the company's official website.
Bodal Chemicals Limited herewith submit Earning presentation
Investor Presentation · 03 Nov 2026, 8:30 pm
Bodal Chemicals Reports Strong Q2FY27 Growth Driven by Margin Expansion Bodal Chemicals posted strong consolidated performance for Q2FY27, with total revenue rising 76.7% YoY to Rs 8,839.6 mn, supported by improved realization and higher volumes. EBITDA surged 197.3% YoY to Rs 1,275.9 mn, expanding EBITDA margin by 580 bps to 14.4%. PAT grew exponentially to Rs 814.4 mn versus Rs 59.9 mn in Q2FY26. Growth was primarily led by Dye Intermediates, up 88% YoY to Rs 3,449 mn, and Dyestuffs, up 60% YoY to Rs 2,115 mn, alongside initial revenue contributions from the Saykha benzene downstream facility.
Bodal Chemicals Limited herewith submit Outcome for financial results for September quarter 2026
Outcome · 03 Nov 2026, 7:49 pm
Bodal Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 03 Nov 2026, 7:45 pm
Bodal Chemicals Reports Strong Q2 FY27 Consolidated Net Profit Surge to Rs 814.44 Million Bodal Chemicals reported a robust performance for the quarter ended 30th Sep'26, with consolidated revenue from operations rising 79.7% YoY to Rs 8,633.74 million compared to Rs 4,804.52 million in the previous year quarter. Consolidated net profit surged over 13-fold YoY to Rs 814.44 million from Rs 59.93 million, supported by operational growth and a prior-year tax credit of Rs 127.17 million. Basic EPS for the quarter rose sharply to Rs 6.48 versus Rs 0.47 in 30th Sep'25.
Bodal Chemicals Limited herewith submit unaudited financial results for quarter and half year ended 30th September 2026
Financial Result · 03 Nov 2026, 7:45 pm
Bodal Chemicals Limited herewith inform exchange about Con Call
Intimation · 03 Nov 2026, 4:30 pm
Bodal Chemicals Schedules 2QFY27 And 1HFY27 Earnings Conference Call Bodal Chemicals Ltd. announced it will host an earnings conference call on 3rd Nov'26 at 4:30 PM IST to discuss its financial results for 2QFY27 and 1HFY27. Organized by Equirus Securities, the call will feature senior management, including Executive Director Ankit S Patel and CFO Mayur Padhya. Universal dial-in access numbers for the call are +91 22 6280 1224 and +91 22 7115 8125, alongside international toll-free numbers for the US, UK, Singapore, and Hong Kong.
Bodal Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ....
Intimation · 03 Nov 2026, 5:30 am
Bodal Chemicals Board Meeting Scheduled for 3rd Nov'26 to Consider Q2 Results Bodal Chemicals has scheduled its Board of Directors meeting on 3rd Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities remains closed for designated insiders and will reopen 48 hours post-declaration of results, effective from 6th Nov'26.
Bodal Chemicals Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 03 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 03 Nov 2026, 5:30 am
Bodal Chemicals Limited submit minutes of 40th Annual General Meeting
Annual General Meeting · 03 Oct 2026, 6:10 pm
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramesh D Patel
Acquisition/ Disposal of Shares · 30 Sept 2026, 8:12 pm
Promoter Ramesh D. Patel Trims Stake in Bodal Chemicals via Open Market Promoter group member Ramesh D. Patel sold 1,70,000 equity shares (representing 0.13% of total voting capital) of Bodal Chemicals Ltd. on 29th Sep'26 via open market inter-se transfer. Following this disposal, Patel's equity holding in the company decreased from 49,45,880 shares (3.93%) to 47,75,880 shares (3.79%). The company's total fully paid-up equity share capital remains unchanged at 12,59,44,065 shares of Rs. 2 each.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ankit S Patel
Acquisition/ Disposal of Shares · 30 Sept 2026, 6:18 pm
Promoter Ankit S. Patel Acquires 0.13% Stake in Bodal Chemicals Promoter group member Ankit S. Patel acquired 1,70,000 equity shares (0.13% stake) of Bodal Chemicals Ltd. via open market inter-se transfer on 29th Sep'26. Following this transaction, Patel's total shareholding in the company increased from 72,61,072 shares (5.77% voting capital) to 74,31,072 shares (5.90% voting capital). The total equity base remains unchanged at 12,59,44,065 shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramesh D Patel
Acquisition/ Disposal of Shares · 30 Sept 2026, 6:14 pm
Bodal Chemicals Promoter Ramesh D Patel Offloads 0.13% Stake via Open Market Promoter Ramesh D Patel sold 1,70,000 equity shares (0.13% stake) of Bodal Chemicals Ltd. on 29th Sep'26 through an open market inter-se transaction. Post-transaction, his shareholding decreased from 49,45,880 shares (3.93%) to 47,75,880 shares (3.79%) of the company's total paid-up voting capital, which comprises 12,59,44,065 equity shares of Rs. 2 each.
Bodal Chemicals Limited herewith submit voting results for Annual General Meeting
Annual General Meeting · 25 Sept 2026, 10:45 pm
Bodal Chemicals Limited herewith submit Scrutinizers Report for 40th Annual General Meeting
Annual General Meeting · 25 Sept 2026, 10:39 pm
Bodal Chemicals Limited herewith submit proceedings / outcome of AGM held on 25th September 2026
Annual General Meeting · 25 Sept 2026, 6:45 pm
Bodal Chemicals Limited herewith submit clarification on social media post for fake news
Others (Uncategorized) · 14 Sept 2026, 8:32 pm
Bodal Chemicals Clarifies False Social Media Merger Rumors Bodal Chemicals Ltd. issued a regulatory clarification on 14th Sep'26 regarding circulating social media claims alleging a merger with a private entity to expand operations. The company confirmed that no such amalgamation is under management consideration, terming the reports entirely fake and baseless. Bodal Chemicals stated it holds no association with the social media handles disseminating the misinformation, affirming full compliance with SEBI (LODR) Regulations, 2015 disclosure norms with no undisclosed material events pending.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashokkumar Giriraj Bansal
Acquisition/ Disposal of Shares · 12 Sept 2026, 8:28 pm
Ashokkumar Giriraj Bansal Acquires Additional Stake in Bodal Chemicals Ashokkumar Giriraj Bansal acquired 1,75,000 equity shares (0.14% stake) of Bodal Chemicals Limited via an open-market transaction on 11th Sep'26. Prior to this acquisition, Bansal held 61,30,000 shares, representing a 4.87% voting share. Post-transaction, total shareholding increased to 63,05,000 shares, crossing the substantial acquisition threshold to reach 5.01% of total diluted voting capital. The company's total voting capital remains unchanged at 12,59,44,065 equity shares of face value Re. 2 each, aggregating Rs. 25,18,88,130. The acquirer does not belong to the promoter group.
Bodal Chemicals Limited herewith inform Exchange about clarification in movement in price/volume
Others (Uncategorized) · 01 Sept 2026, 4:04 pm
The Exchange has sought clarification from Bodal Chemicals Ltd on August 31, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Others (Uncategorized) · 01 Sept 2026, 1:05 am
Bodal Chemicals Limited herewith submit Annual Report for year ended 31st March 2026. AGM scheduled to be held on 25th September 2026
Others (Uncategorized) · 31 Aug 2026, 10:09 pm
Bodal Chemicals Limited herewith submit Notice of Annual General Meeting scheduled to be held on 25th September 2026
Annual General Meeting · 31 Aug 2026, 9:57 pm
Bodal Chemicals Limited herewith inform Exchange about Book Closure, E-Voting and Date of Annual General Meeting
Annual General Meeting · 17 Aug 2026, 8:19 pm
Bodal Chemicals Limited herewith inform exchange about earning presentation
Investor Presentation · 06 Aug 2026, 12:12 am
Bodal Chemicals Q1FY27: Robust Topline Growth and Margin Pressure Bodal Chemicals reported strong Q1FY27 results with consolidated revenue of Rs. 7,152 mn, up 56% YoY, driven by higher realizations and volumes. Key segments like Dye Intermediates (+44%), Basic Chemicals (+89%), and Dyestuff (+23%) showed robust growth. EBITDA grew 45% YoY to Rs. 751 mn, but margins contracted to 10.5% from 11.3% due to higher raw material costs. Consolidated PAT surged 219% YoY to Rs. 304 mn. The new Benzene downstream division started contributing to the topline this quarter.
Bodal Chemicals Limited herewith submit outcome and financial results for quarter ended 30th June 2026
Financial Result · 06 Aug 2026, 12:01 am
Bodal Chemicals Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Million) ■ Revenue: 7,090 (+56.1% YoY | +20.6% QoQ) ■ EBITDA: 689 (+44.8% YoY | +0.6% QoQ) ■ EBITDA Margin (%): 9.7 (-76 bps YoY | -194 bps QoQ) ■ PAT: 304 (+218.7% YoY | -5.2% QoQ) ■ EPS (INR): 2.41 (+217.1% YoY | -5.5% QoQ)